AAJ KI DELHI/INDIAN NEWS ONLINE
In India, Hyderabad-based vaccine manufacturer Bharat Biotech, which has been working on developing an intra-nasal drop vaccine for COVID-19, has initiated testing in the United States in collaboration with the University of Wisconsin-Madison and vaccine developer FluGen, CNBC-TV18 reported on Tuesday.
In India, Hyderabad-based vaccine manufacturer Bharat Biotech, which has been working on developing an intra-nasal drop vaccine for COVID-19, has initiated testing in the United States in collaboration with the University of Wisconsin-Madison and vaccine developer FluGen, CNBC-TV18 reported on Tuesday.
The development comes a week after Pune-based Serum Institute said it hopes to begin human trials for its vaccine by the end of the year.
Meanwhile, Bharat Biotech is hoping that its CoroFlu vaccine is ready for human trials by the end of this year.
“We are working with one of the COVID-19 nasal-flu vaccines in collaboration with University of Wisconsin. We have completed R&D experiments and now it is going through animal trials," Dr Krishna Ella, Chairman and MD of Bharat Biotech, told CNBC-TV18. "We are looking at animals because as the vaccine has some problems similar to that of dengue. So, you need to be cautious in animal testing to ensure the safety of people."
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.